Dr.K.Bhavya Sri

Name: Dr.K.Bhavya Sri
Qualification:M.Pharmacy,Ph.D
Designation:Associate professor
Experience:6.11years
Teaching Experience:6.11years
Industrial Experience:1 year
Research Experience:
Research Experience:
Publications -international

  1. Simultaneous Determination of Valsartan and Hydrochlorothiazide in Human plasma by LC-MS/MS Method.
  2. A Validated LC Method for Determination of 2,3-Dichlorobenzoic Acid and its Associated Regio Isomers.
  3. Separation of Enantiomers of Clopidogrel on Chiral Stationary Phases by Packed column Supercritical Fluid Chromatography.
  4. Separation of the two Enantiomers of Gatifloxacin by SFC on amylose based stationary phase.
  5. RP-UPLC method development and validation for the simultaneous estimation of Proguanil and Atovaquone in pharmaceutical dosage form.
  6. Rapid simultaneous determination of Naproxen and Esomeprozole magnesium in combined tablets by validated ultra performance liquid chromatographic method.
  7. Bioanalytical method development and validation of Milnacipran in rat plasma by LC–MS/MS detection and its application to a pharmacokinetic study.
  8. Quantification of Etravirine in Rat Plasma by LC-MS/MS and    Application to a Pharmacokinetic Study.
  9. Development and Validation of A Supercritical Fluid Liquid Chromatographic Method For Determination of Enantiomeric Purity of Atorvastatin In Bulk Drugs And Pharmaceuticals.
  10. A Validated Bio- analytical method for quantification of Ziprasidone in Rabbit plasma by LC-MS/MS: application to a pharmacokinetic study.
  11. Development and Validation Of Forced Degradation Studies Of Rasagiline Mesylate Using RP-HPLC And Characterization Of Degradants By LC-MS/MS.
  12. Development and validation of forced degradation studies of Raltegravir using RP-HPLC and characterization of degradants by LC-MS/MS.
  13. Development and Validation Of Forced Degradation Studies Of Lopinavir Using RP-HPLC And Characterization Of Degradants By LC-MS/MS.
  14. Development and Validation of Piribedil in Tablet Dosage Form by HPLC: A QbD and OFAT Approach.
  15. Stability-Indicating RP-UPLC Method Development and Validation for the Process Related Impurities of Nebivolol and Structural Characterization of Its Forced Degradation Products by LC-MS/MS.
  16. HPLC Method for Determining Esomeprazole and its Related Substances in Pharmaceutical Formulations
Presentations-8 international and 23 national

 

Achievements